CRWOF(CRWOF)
CRWOF
No analyst ratings available
No analyst price targets available for CRWOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.06T | $1.06T | $1.07T |
| Low | $977.11B | $995.53B | $996.50B |
| High | $1.15T | $1.19T | $1.18T |
| EBITDA Avg | $85.67B | $85.82B | $86.63B |
| Low | $78.79B | $80.28B | $80.36B |
| High | $92.55B | $95.74B | $95.11B |
| EBIT Avg | $56.36B | $56.46B | $56.99B |
| Low | $51.84B | $52.81B | $52.86B |
| High | $60.89B | $62.99B | $62.57B |
| Net Income Avg | $22.36B | $22.38B | $23.01B |
| Low | $20.25B | $20.27B | $20.85B |
| High | $25.20B | $25.22B | $25.94B |
| EPS Avg | $0.91 | $0.91 | $0.94 |
| Low | $0.82 | $0.82 | $0.85 |
| High | $1.02 | $1.03 | $1.05 |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 6 / 1 |